Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-016352
Filing Date
2021-04-20
Accepted
2021-04-20 07:00:19
Documents
2
Period of Report
2021-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1692
2 EX-24 DOCUMENT attachment1.htm EX-24 3776
  Complete submission text file 0000899243-21-016352.txt   7073
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Issuer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UROVANT SCIENCES, INC. 5281 CALIFORNIA AVENUE, SUITE 100 IRVINE CA 92617
Business Address
Smith Bryan E. (Reporting) CIK: 0001748041 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36620 | Film No.: 21836269